NCT05050383

Brief Summary

Drug-induced sleep endoscopy (DISE) represents an opportunity to evaluate the upper airway in sleep-like conditions. In its current clinical form, however, DISE does not routinely determine the functional impact of anatomic and neuromuscular factors on airflow obstruction. The investigators will apply nasal pressure (CPAP) during DISE to generate pressure-flow and pressure-area relationships, deriving functional determinants of upper airway obstruction during sleep. In addition, they will use objective anatomic measurements from computerized tomography (CT) and submental ultrasound. The findings will allow the investigators to streamline the upper airway exam during DISE, and will further the goal of developing personalized solutions that address specific pathogenic mechanisms of pharyngeal collapse and airflow obstruction during sleep. The investigators will use the physiologic and anatomic features derived from DISE and imaging to determine which are predictive of success to standard-of-care surgical interventions (e.g. skeletal, soft tissue, neurostimulation) .

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
241

participants targeted

Target at P75+ for not_applicable

Timeline
16mo left

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Nov 2021Sep 2027

First Submitted

Initial submission to the registry

September 9, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

November 12, 2021

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

August 13, 2025

Status Verified

July 1, 2025

Enrollment Period

4.8 years

First QC Date

September 9, 2021

Last Update Submit

August 8, 2025

Conditions

Keywords

sleep apneadrug-induced sleep endoscopysnoring

Outcome Measures

Primary Outcomes (1)

  • Identify the pathogenic determinants of airway obstruction at specific sites of pharyngeal collapse by characterizing upper airway pressure-flow/area relationships during DISE to predict responses to upper airway surgery

    Change in pre-operative to post-operative AHI

    Within 1 year of enrollment

Secondary Outcomes (4)

  • Correlation of anatomic measurements from computerized tomography (CT) scans to physiologic findings from DISE

    Within 3 months of enrollment

  • Complement videoendoscopic DISE findings with synchronous ultrasound imaging

    Within 3 months of enrollment

  • Compare positive airway pressure levels obtained from natural sleep to those during DISE

    Within 3 months of enrollment

  • Examine outcomes associated with non-surgical treatments (e.g. oral appliance therapy)

    Within 1 year of enrollment

Study Arms (1)

Drug-Induced Sleep Endoscopy

OTHER

Drug-Induced Sleep Endoscopy

Other: Pharyngeal ManometryOther: Submental Ultrasound

Interventions

Catheters will be passed into the nose and advanced to the pharynx to measure airway pressures during drug-induced sleep.

Drug-Induced Sleep Endoscopy

Ultrasound of airway soft tissues

Drug-Induced Sleep Endoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥ 18yrs) willing and capable of providing informed consent.
  • English-speaking \& able to give Informed Consent.
  • Referred or scheduled for clinically indicated DISE procedure.
  • Seeking CPAP alternatives for treatment of sleep disordered breathing.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea SyndromesSnoring

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesRespiratory SoundsSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Raj C Dedhia, MD, MSCR

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Director of Sleep Surgery

Study Record Dates

First Submitted

September 9, 2021

First Posted

September 20, 2021

Study Start

November 12, 2021

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2027

Last Updated

August 13, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations